Jiangsu Recbio Technology Co., Ltd. (2179.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap1.91B
Enterprise Value2.2B
P/E Ratio-4.89
PEG Ratio-0.09
Price/Sales Ratio214.93
Price/Book Ratio4.66
Enterprise/Revenue267.18
Enterprise/EBITDA-6.94

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-51.34
Operating Margin-50.01
AD

Management Effectiveness

Return On Assets-0.3
Return On Equity-0.79

Income Statement

Revenue12.4M
Revenue/Share0.02
Gross Profit-91.46M
EBITDA-486.44M
Net Income-594.59M
Diluted EPS-1.12

Balance Sheet

Total Cash187.51M
Total Cash/Share0.3
Total Debt672.99M
Total Debt/Equity1.35
Current Ratio0.53
Book Value Per Share0.81

Price History

52-Week Change-38.39
52-Week High7.2
52-Week Low3.4
Moving Average 50 Days4.91
Moving Average 200 Days4.81

Statistics

Average Volume960
Shares Outstanding530.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD